Comprehensive molecular biomarker identification in breast cancer brain metastases

BACKGROUND: Breast cancer brain metastases (BCBM) develop in about 20–30% of breast cancer (BC) patients. BCBM are associated with dismal prognosis not at least due to lack of valuable molecular therapeutic targets. The aim of the study was to identify new molecular biomarkers and targets in BCBM by...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulten, Hans-Juergen, Bangash, Mohammed, Karim, Sajjad, Dallol, Ashraf, Hussein, Deema, Merdad, Adnan, Al-Thoubaity, Fatma K., Al-Maghrabi, Jaudah, Jamal, Awatif, Al-Ghamdi, Fahad, Choudhry, Hani, Baeesa, Saleh S., Chaudhary, Adeel G., Al-Qahtani, Mohammed H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747948/
https://www.ncbi.nlm.nih.gov/pubmed/29287594
http://dx.doi.org/10.1186/s12967-017-1370-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747948/
https://www.ncbi.nlm.nih.gov/pubmed/29287594
http://dx.doi.org/10.1186/s12967-017-1370-x

Ejemplares similares